Full name
SOPHARMA WARSZAWA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.46.Z - Wholesale of pharmaceutical goods
46.45.Z - Wholesale of perfume and cosmetics
46.90.Z - Non-specialised wholesale trade
47.73.Z - Dispensing chemist in specialised stores
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
47.75.Z - Retail sale of cosmetic and toilet articles in specialised stores
52.10.B - Warehousing and storage of other goods
58.19.Z - Other publishing activities
72.19.Z - Other research and experimental development on natural sciences and engineering
73.20.Z - Market research and public opinion polling
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,6 | -0,4 | -1,6 | -253,5 |
EBITDA | 0,7 | -0,3 | -1 | -202,7 |
Short time liabilities | 0,6 | 3,7 | 9 | 141,6 |
Equity capital | 6,4 | 6,1 | 40 | 559,4 |
Operating profit (EBIT) | 0,7 | -0,3 | -1,9 | -480 |
Assets | 7,2 | 10 | 49,3 | 392,9 |
Net profit (loss) | 0,4 | -0,4 | -1,3 | -242 |
Cash | 1,3 | 4 | 4 | 1,2 |
Net income from sale | 13,8 | 13,5 | 17 | 25,4 |
Liabilities and provisions for liabilities | 0,8 | 3,9 | 9,3 | 135,7 |
Working assets | 7,1 | 9,9 | 21,5 | 118,6 |
Depreciation | 0 | 0 | 0,9 | 11 339,4 |
% | % | % | p.p. | |
Profitability of capital | 6,9 | -6,3 | -3,3 | 3 |
Equity capital to total assets | 89,6 | 60,7 | 81,2 | 20,5 |
Gross profit margin | 4 | -3,3 | -9,2 | -5,9 |
EBITDA Margin | 5,2 | -2,4 | -5,8 | -3,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 16 | 101 | 194 | 93 |
Current financial liquidity indicator | 10.573450088500977 | 2.6112148761749268 | 2.3765065670013428 | -0,2 |
Net dept to EBITDA | -1.7702208757400513 | 12.209957122802734 | 4.082596302032471 | -8,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane